Clinical Trial Update: Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on assessing molecular remission by ASO-qPCR after bortezomib-dexamethasone induction followed by autologous stem cell transplant in multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Velcade (bortezomib)

Snippet

Sponsor: Tampere University Hospital | Conditions: Multiple Myeloma | Phase 2, Phase 3 | Status: COMPLETED